Clinical Trial

Pharmacogenomics-Supported Psychotropic Prescribing Trial

Name: Pharmacogenomics-Supported Psychotropic Prescribing Trial — clinical trial record (NCT06929533)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Study acronym: PGx-SUPPORT

Recruiting

View on ClinicalTrials.gov →

Summary

Investigate the feasibility and utility of implementing pharmacogenetic testing for adults (aged 18 and older) seeking care for mental illness in Manitoba.

Protocol Amendment History 1 amendment

This ClinicalTrials.gov record has been amended once since 2025-04-14.

Status change: Not Yet Recruiting → Recruiting 2025-09-01

Trial Details

NCT Number	NCT06929533
Lead Sponsor	University of Manitoba Collaborators: University of Calgary, Shared Health Manitoba, Winnipeg Regional Health Authority, Health Sciences Centre, Winnipeg, Manitoba
Conditions	Mental Disorder, Pharmacogenetics, Adverse Drug Reaction (ADR), Effectiveness
Enrollment	200 participants
Start Date	2025-07-01
Primary Completion	2028-12-31 (estimated)
Study Completion	2030-12-31 (estimated)
Updated on ClinicalTrials.gov	2025-09-08